UBS O'Connor’s Arcus Biosciences RCUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-52,975
Closed -$431K 416
2025
Q2
$431K Sell
52,975
-75,713
-59% -$647K 0.01% 277
2025
Q1
$1.01M Buy
128,688
+52,042
+68% +$603K 0.02% 187
2024
Q4
$1.14M Buy
76,646
+44,784
+141% +$731K 0.03% 215
2024
Q3
$487K Sell
31,862
-33,325
-51% -$525K 0.01% 346
2024
Q2
$993K Buy
65,187
+1,065
+2% +$17.2K 0.03% 297
2024
Q1
$1.21M Buy
64,122
+10,876
+20% +$188K 0.03% 257
2023
Q4
$1.02M Sell
53,246
-46,166
-46% -$738K 0.03% 267
2023
Q3
$1.78M Sell
99,412
-5,000
-5% -$100K 0.03% 261
2023
Q2
$2.12M Sell
104,412
-10,068
-9% -$192K 0.04% 284
2023
Q1
$2.09M Buy
+114,480
New +$2.19M 0.05% 306
2022
Q4
Sell
-38,725
Closed -$1.01M 253
2022
Q3
$1.01M Sell
38,725
-11,700
-23% -$309K 0.01% 748
2022
Q2
$1.28M Buy
+50,425
New +$1.23M 0.01% 736

Other funds holding RCUS